1.A Case of Hematometrocolpos due to Complete Septate Uterus and Obstructed Hemivagina associated with Ipsilateral Renal Agenesis.
Sun Hee CHA ; Hyun Haing LEE ; Hyun Chul KIM ; Mee Hwa LEE ; Suk Kyung KIM
Korean Journal of Obstetrics and Gynecology 2000;43(1):104-108
We report a case of a 13-year-old girl who was noted to have combined malformation of complete septate uterus, obstructed hemivagina and ipsilateral renal agenesis with complaints of dysmenorrhea. Hematometrocolpos was developed in the result of retained menstrual blood since menarche. This rare congenital anomaly is supposed to be derived from disorders of mesonephric and M llerian developement in embryogenesis of female genitouinary tract. An accurate preoperative diagnosis of this syndrome is critical because of the difference in therapeutic strategy and prognosis. Simple and definite treatment of the condition is excision of the obstructed vaginal septum with prompt exit of retained blood. We present here a interesting case of M llerian anomaly in attempt to alert gynecologist to the possible occurrence of such a malformation with a brief review of concerned literatures.
Adolescent
;
Diagnosis
;
Dysmenorrhea
;
Embryonic Development
;
Female
;
Humans
;
Menarche
;
Pregnancy
;
Prognosis
;
Uterus*
2.A Case of Recurrent Leiomyoma in Vesicovaginal Septum.
Yong Hee LEE ; Hyun Haing LEE ; Byung Sun BAE ; Myung Chul SHIN ; Wee Hyun LEE ; Kye Weon KWON
Korean Journal of Obstetrics and Gynecology 1998;41(11):2883-2885
Leiomyoma of vagina is relatively rare benign tumor. And majority of these lesions occur in labia major and anterior vaginal wall. The recurrence of this tumor is extremely rare and its cellular atypism, mitotic activity, tumor size and contour are known as important factors in its recutrence. A case of recutrent leiomyoma causing urinary frequency in vesicovaginal septum was reported with a brief review of literature.
Leiomyoma*
;
Recurrence
;
Vagina
3.Effect of Central Vacuum Scavenger in Controlling Air Pollution in the Operating Room due to Halothane.
Man Mo YOON ; Min Hae YEH ; Sun Haing LEE ; Sung Kyung CHO ; Bong II KIM ; Sang Wha LEE
Korean Journal of Anesthesiology 1985;18(3):234-243
A central vacuum scavenger modified by the authors, was used to control the atmospheric contamination of the operating room by anesthetic gases and vapours. Air pollution was monitored by measuring the concentrations of halothane vapour in the air of the operating room with the gas chromatograph. Under endotrachal intubation, the semi-colsed circle absorber system was used for anesthetic administration and maintained with 0.8~1.2% Halothane. Total gas flow rates were 4 liter/min with 50% oxygen in nitrous oxide for daily work. Air sampling was taken early in the morning at 10cm high from the floor before anesthesia. After daily work, they were also done at 10cm, 120cm, and 140cm high from the floor and at the corridor of the operating room. We investigated the differences of halothane concentration according to each sits by the changing central vacuum pressure. Results are followings: The atmospheric halothane concentration of the operating room before anesthesia were 0.27+/-0.12, 0.22+/-0.11 and 0.15+/-0.06 ppm.The atmospheric halothane concentration of the operating room after daily work were 7.94 +/- 1.30 ppm without the active central vacuum pressure.The atmospheric halothane concentration of the operating room after daily work were 1.41 +/-0.48ppm of 20mmHg of central vacuum pressure.The tmospheric halothane concentration of the operating room after daily work were 0.49+/-0.18ppm of 40mmHg of central vacuum pressure. The atmospheric halothane concentrations at the corridor of the operating room after daily work were 1.09+/-0.19, 0.77+/-0.11n and 0.36+/-0.17ppm when each vacuum pressure was 0mmHg, 20mmHg and 40mmHg. A significant reduction (p<0.01) in atmospheric halothane concentration of the operation room was obtained by the use of the central vacuum pressure with the scavenger. The higher the vacuum pressure, the greater reduction of the operating room air pollution was observed.
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid
;
Air Pollution*
;
Anesthesia
;
Anesthetics, Inhalation
;
Halothane*
;
Intubation
;
Nitrous Oxide
;
Operating Rooms*
;
Oxygen
;
Vacuum*
4.A Clinical Study of Unruptured Ectopic Pregnancies with the Treatment of Systemic or Local Methotrexate Injecton.
Hyun Haing LEE ; Yong Sung CHOI ; Suk Kyung KIM ; Eun Hye LEE ; Yu Seon MIN ; Sang Hee LEE ; Yoo Mee LEE ; Hyeon Chul KIM ; Tae Won SUNWOO ; Chan LEE ; Sung Woon CHANG ; Sun Hee CHA ; Jin Ho CHO
Korean Journal of Obstetrics and Gynecology 2000;43(4):616-624
OBJECTIVE: To evaluate safety and efficacy of systemic or local methotrexate(MTX) injection to patients with unruptured ectopic pregnancy METHODS: From October 1995 to October 1999, 35 unruptured ectopic pregnancies were eligible for the conservative management. 25 tubal pregnancies, 4 cervical pregnancies, 4 pregnancies of previous cesarean section scar, and 2 cornual pregnancies diagnosed by ultrasonography & serumbeta-hCG were evaluated. Patients were treated with one of following three protocols : (1) A single-dose of 50mg/m2 of intramuscullar(IM) MTX(7 cases) (2) Two to four doses of 1.0mg/kg of IM MTX with citrovorum rescue(20 cases) (3) Transvaginal ultrasonogram-guided intra-amniotic instillation of 50mg methotrexate (8 cases) The mean age of these patients was 30.8 yrs (range 24-42) and gestational age at diagnosis ranged from 22-75 days (mean 47). Initial level of serumbeta-hCG ranged from 166.4-55363.8 mIU/mL (mean 9069.2). Patients were monitored with serumbeta-hCG titers three times per week ,and then weekly until the serumbeta-hCG level was less then 10 mIU/mL. RESULT: 31 of 35 patients (88.6%) were successfully treated and remaining 4 patients failed conservative therapy and so required surgery. Mean duration of resolution was 38.5 days (range 11-105). Side effect rate was 45.7% but severity of symptoms were so mild that no treatment was needed in most cases. CONCLUSION: Nonsurgical conservative management of MTX appears to be effective and safe treatment modality for some selected unruptured ectopic pregnancy. But further comparative studies and long-term follow-up are needed to evaluate reproductive outcome and reduce side effects of MTX.
Cesarean Section
;
Cicatrix
;
Diagnosis
;
Female
;
Follow-Up Studies
;
Gestational Age
;
Humans
;
Methotrexate*
;
Pregnancy
;
Pregnancy, Ectopic*
;
Pregnancy, Tubal
;
Ultrasonography
5.Effects of carnosine and related compounds on monosaccharide autoxidation and H2O2 formation.
Beom Jun LEE ; Kyung Sun KANG ; Sang Yoon NAM ; Jae Hak PARK ; Yong Soon LEE ; Young Won YUN ; Myung Haing CHO
The Korean Journal of Physiology and Pharmacology 1999;3(3):251-261
The effects of carnosine and related compounds (CRCs) including anserine, homocarnosine, histidine, and beta-alanine on monosaccharide autoxidation and H2O2 formation were investigated. The incubation of CRCs with D-glucose, D-glucosamine, and D, L-glyceraldehyde at 37degreeC increased the absorption maxima at 285 nm, 273 nm, and 290 ~ 330 nm, respectively. D, L-glyceraldehyde was the most reactive sugar with CRCs. The presence of copper strongly stimulated the reaction of carnosine and anserine with D-glucose or D-glucosamine. Carnosine and anserine stimulated H2O2 formation from D-glucose autoxidation in a dose-dependent manner in the presence of 10 muM Cu (II). The presence of human serum albumin (HSA) decreased their effect on H2O2 formation. Carnosine and anserine has a biphasic effect on alpha-ketoaldehyde formation from glucose autoxidation. CRCs inhibited glycation of HSA as determined by hydroxymethyl furfural, lysine residue with free epsilon-amino group, and fructosamine assay. These results suggest that CRCs may be protective against diabetic complications by reacting with sugars and protecting glycation of protein.
Absorption
;
Anserine
;
beta-Alanine
;
Carbohydrates
;
Carnosine*
;
Copper
;
Diabetes Complications
;
Free Radicals
;
Fructosamine
;
Furaldehyde
;
Glucose
;
Histidine
;
Humans
;
Lysine
;
Serum Albumin
6.The Reliability and Validity of The Migraine-Specific Quality of Life Questionnaire for Korean Migraine Suffers.
Heui Soo MOON ; Chin Sang CHUNG ; Hye Seung LEE ; Hye Sun PARK ; Seon Woo KIM ; Haing Won WOO
Journal of the Korean Neurological Association 2003;21(2):146-155
BACKGROUND: Recurrent, often unpredictable, migraine attacks significantly interfere with daily functioning and productivity of patients with migraine. Quality of life measurement represents an important tool for evaluating migraine therapy and judging the impact of headache either on individuals or on society. The objective of this study was to test the reliability and validity of the translated version of MSQoL (Migraine-Specific Quality of Life) in Korean migraine patients. METHODS: Participants, migraineurs from the Samsung Medical Center Migraine Clinic, were screened using the International Headache Society migraine criteria prior to enrollment through direct interview. This survey included the MSQoL, MIDAS (Migraine Disability assessment) and STAI (State-Trait Anxiety Inventory). RESULTS: Sixty-five migraineurs were recruited. For the MSQoL, Cronbach's alpha was 0.93. Frequency and number of accompanying symptoms were predictive of the MSQoL. The negative correlation between the MSQoL scores and the MIDAS score was seen (r=-0.585, p<0.01). Similarly a negative correlation between the MSQoL scores and duration of headache was also observed (r=-0.38, p<0.01). Although a significant negative correlation between the MSQoL and STAI scores was present (r=-0.47, p<0.01), correlation between the MIDAS and the STAI scores was not significant. CONCLUSIONS: The MSQoL is a reliable and valuable migraine-specific quantitative tool to assess the degree of quality of life in Korean migraineurs. It has a potential to provide valuable information on migraineur's disability and anxiety level. The MSQoL has acceptable psychometric properties and can be used to estimate long-term outcome of migraine therapy in Korean population.
Anxiety
;
Efficiency
;
Headache
;
Humans
;
Migraine Disorders*
;
Psychometrics
;
Quality of Life*
;
Surveys and Questionnaires*
;
Reproducibility of Results*
7.Serum immunoglobulin fused interferon-alpha inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells.
Jun Sung KIM ; Kyeong Nam YU ; Mi Suk NOH ; Min Ah WOO ; Sung Jin PARK ; Jin Hong PARK ; Jin HUA ; Hyun Sun CHO ; Soon Kyung HWANG ; Eun Sun LEE ; Youn Sun CHUNG ; In Young CHOI ; Se Chang KWON ; Myung Haing CHO
Journal of Veterinary Science 2008;9(1):45-50
Interferon (IFN) has therapeutic potential for a wide range of infectious and proliferative disorders. However, the half-life of IFN is too short to have a stable therapeutic effect. To overcome this problem, serum immunoglobulin has been fused to IFN. In this study, the efficacy of serum immunoglobulin fused INFs (si-IFN1 and si-IFN2) was evaluated on athymic mice bearing colon 26 adenocarcinoma cells. Seven days after the implantation of tumor cells, each group of mice was injected once a week with si-IFN1 and si-IFN2 at two different concentrations (10 x : 30 microgram/kg and 50 x : 150 microgram/kg). A slight anti-tumoral effect was observed in all 10 x groups compared to the control. In the 50 x groups, however, si-IFN1 and si-IFN2 showed significant anti- tumoral effects compared to the control. To gain more information on the mechanisms associated with the decrease of tumor size, a Western blot assay of apoptosis-related molecules was performed. The protein expression of cytochrome c, caspase 9, 6, and 3 were increased by si-IFN1 and si-IFN2. These 2 IFNs also increased the expressions of p53, p21, Bax and Bad. Interestingly, si-IFN1 and si-IFN2 decreased the expression of VEGF-beta. Taken together, serum immunoglobulin fused IFNs increased therapeutic efficacy under current experimental condition.
Adenocarcinoma/*drug therapy
;
Alanine Transaminase/blood
;
Animals
;
Antineoplastic Agents/chemistry/pharmacology
;
Blood Urea Nitrogen
;
Dose-Response Relationship, Drug
;
Immunoglobulins/*chemistry/*pharmacology
;
Interferon Alfa-2a/chemistry/pharmacology
;
Interferon-alpha/*chemistry/*pharmacology
;
Mice
;
Mice, Nude
;
Neoplasms, Experimental/*drug therapy
;
Polyethylene Glycols/chemistry/pharmacology
;
Recombinant Fusion Proteins/chemistry/pharmacology
8.Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells.
Hyun Sun CHO ; Seung Hee CHANG ; Youn Sun CHUNG ; Ji Young SHIN ; Sung Jin PARK ; Eun Sun LEE ; Soon Kyung HWANG ; Jung Taek KWON ; Arash Minai TEHRANI ; Minah WOO ; Mi Sook NOH ; Huda HANIFAH ; Hua JIN ; Cheng Xiong XU ; Myung Haing CHO
Journal of Veterinary Science 2009;10(1):23-28
Tetrandrine (TET), a bis-benzylisoquinoline alkaloid from the root of Stephania tetrandra, is known to have anti-tumor activity in various malignant neoplasms. However, the precise mechanism by which TET inhibits tumor cell growth remains to be elucidated. The present studies were performed to characterize the potential effects of TET on phosphoinositide 3-kinase/Akt and extracellular signal-regulated kinase (ERK) pathways since these signaling pathways are known to be responsible for cell growth and survival. TET suppressed cell proliferation and induced apoptosis in A549 human lung carcinoma cells. TET treatment resulted in a down-regulation of Akt and ERK phosphorylation in both time-/concentration-dependent manners. The inhibition of ERK using PD98059 synergistically enhanced the TET-induced apoptosis of A549 cells whereas the inhibition of Akt using LY294002 had a less significant effect. Taken together, our results suggest that TET: i) selectively inhibits the proliferation of lung cancer cells by blocking Akt activation and ii) increases apoptosis by inhibiting ERK. The treatment of lung cancers with TET may enhance the efficacy of chemotherapy and radiotherapy and increase the apoptotic potential of lung cancer cells.
Antineoplastic Agents, Phytogenic/*pharmacology
;
Apoptosis/drug effects
;
Benzylisoquinolines/*pharmacology
;
Carcinoma/*drug therapy
;
Cell Line, Tumor
;
Dose-Response Relationship, Drug
;
Extracellular Signal-Regulated MAP Kinases/*antagonists & inhibitors
;
Humans
;
Lung Neoplasms/*drug therapy
9.Low dietary inorganic phosphate affects the lung growth of developing mice.
Cheng Xiong XU ; Hua JIN ; Youn Sun CHUNG ; Ji Young SHIN ; Soon Kyung HWANG ; Jung Taek KWON ; Sung Jin PARK ; Eun Sun LEE ; Arash MINAI-TEHRANI ; Seung Hee CHANG ; Min Ah WOO ; Mi Suk NOH ; Gil Hwan AN ; Kee Ho LEE ; Myung Haing CHO
Journal of Veterinary Science 2009;10(2):105-113
Inorganic phosphate (Pi) plays a critical role in diverse cellular functions, and regulating the Pi balance is accomplished by sodium-dependent Pi co-transporter (NPT). Pulmonary NPT has recently been identified in mammalian lungs. However, to date, many of the studies that have involved Pi have mainly focused on its effect on bone and kidney. Therefore, current study was performed to discover the potential effects of low Pi on the lung of developing transgenic mice expressing the renilla/firefly luciferase dual reporter gene. Two-weeks old male mice divided into 2 groups and these groups were fed either a low PI diet or a normal control diet (normal: 0.5% Pi, low: 0.1% Pi) for 4 weeks. After 4 weeks of the diet, all the mice were sacrificed. Their lungs were harvested and analyzed by performing luciferase assay, Western blotting, kinase assay and immunohistochemistry. Our results demonstrate that low Pi affects the lungs of developing mice by disturbing protein translation, the cell cycle and the expression of fibroblast growth factor-2. These results suggest that optimally regulating Pi consumption may be important to maintain health.
Animals
;
Blotting, Western
;
Carrier Proteins/metabolism
;
Immunohistochemistry
;
Lung/drug effects/enzymology/*growth & development/metabolism
;
Male
;
Mice
;
Mice, Transgenic
;
Phosphoproteins/metabolism
;
Phosphorus, Dietary/*administration & dosage
;
Phosphorylation
;
Phosphotransferases (Alcohol Group Acceptor)/metabolism
;
Proto-Oncogene Proteins c-akt/metabolism
;
Sodium-Phosphate Cotransporter Proteins, Type IIa/*metabolism
10.The Study for Switching Methods to Olanzapine in Korean Schizophrenic Patients Treated with Other Antipsychotics(I): Comparison of Therapeutic Effecacy.
Yong Min AHN ; Kyung Bong KOH ; Young Jin KOO ; Leen KIM ; Kyung Joon MIN ; Ki Chang PARK ; Ho Suk SUH ; Jong Ho SONG ; Haing Won WOO ; Bum Hee YU ; Dong Woo LEE ; Chung Tai LEE ; Sang Ick HAN ; Sun Ho HAN ; Chang Hwan HAN ; Yong Sik KIM
Journal of Korean Neuropsychiatric Association 2002;41(5):876-889
OBJECTIVES: This randomized, multicenter, open-label, parallel clinical trial was carried to compare the therapeutic efficacy and the proportion of successful switch between 'direct switching method' and 'start-tapering switching method' when switching an antipsychotic to olanzapine. METHODS: This study included both inpatients and outpatients who fulfilled the criteria for schizophrenia as defined in the ICD-10 from 13 hospitals, and were in need to be appropriate for switching antipsychotics. Subjects were randomly assigned to one of the two switching methods. For 'direct switching method' group, previous antipsychotics were abruptly discontinued and 10mg of olanzapine was administered, whereas for 'start-tapering switching method' group, initially 10mg of olanzapine was administered and previous antipsychotics was gradually tapered for 2 weeks. Olanzapine was used for 6 weeks and the dose was adjusted within the range of 5-20mg. The therapeutic efficacy was measured with PANSS, BPRS, and CGI-Severity. A successful switching was defined as the completion of the 6 week trial without either worsening of the symptom(i.e. CGI-S score becomes worse twice consecutively) or the exacerbation of extrapyramidal symptoms(i.e. Simpson-Angus Scale scores becomes worse). RESULTS: 103 schizophrenic patients were participated in this study. There were no differences in baseline characteristics such as the demographic variables, the severity of symptoms, the history of previous antipsychotics treatments, the dosage of olanzapine used and the compliance between two groups. The proportion of successful switch was 71.1% for "direct switching method" and 82.2% for "start-tapering switching method", and there was no significant difference between the two switching methods. Also response rates to olanzapine based on total PANSS total scores were not different between the two groups(26.9% vs. 31.1%). At the time of completion of the trial, the scores of PANSS total, PANSS subscales, CGI-S and BPRS have significantly decreased after switching to olanzapine. But the changes of all scales measuring therapeutic efficacy in both endpoint and weekly analyses were not significantly different between the two switching methods. CONCLUSION: Although this study trial has many limitations and problems as an open clinical trial, the results may suggest that there were no significant differences between the two switching methods in the therapeutic efficacy. It was also found that the additional therapeutic benefits could be obtained by switching their antipsychotics to olanzapine.
Antipsychotic Agents
;
Compliance
;
Humans
;
Inpatients
;
International Classification of Diseases
;
Outpatients
;
Schizophrenia
;
Weights and Measures